Synapse - Works

Results (4808)

Prognostic factors in myoepithelial carcinoma of salivary glands: A clinicopathologic study of 48 cases

Journal Article

Kong, M.; Drill, E. N.; Morris, L.; West, L.; Klimstra, D.; Gonen, M.; Ghossein, R.; Katabi, N.
American Journal of Surgical Pathology (2015)

Fulltext@MSK | Save

Semiautomated CT-based quantification of donor kidney volume applied to a predictive model of outcomes in renal transplantation

Journal Article

Juluru, K.; Rotman, J. A.; Masi, P.; Spandorfer, R.; Ceraolo, C. A.; Giambrone, A. E.; Serur, D.; Hartono, C.
American Journal of Roentgenology (2015)

Fulltext@MSK | Save

Synthesis and pharmacology of halogenated δ-opioid-selective [D-Ala2]deltorphin II peptide analogues

Journal Article

Pescatore, R.; Marrone, G. F.; Sedberry, S.; Vinton, D.; Finkelstein, N.; Katlowitz, Y. E.; Pasternak, G. W.; Wilson, K. R.; Majumdar, S.
ACS Chemical Neuroscience (2015)

Fulltext@MSK | Save

Cost-effectiveness analysis of arsenic trioxide for the treatment of in patients with acute promyelocytic leukemia

Meeting Abstract

Tallman, M.; Lo-Coco, F.; Barnes, G.; Kruse, M.; Wildner, R.; Martin, M.; Mueller, U.; Tang, B.; Pathak, A.; Weinstein, M. C.
Value in Health (2015)

Fulltext@MSK | Save

Cost comparison of first line metastatic renal cell carcinoma treatments using a retrospective claims dataset

Meeting Abstract

Margolis, J.; Princic, N.; Doan, J.; Lenhart, G.; Motzer, R.
Value in Health (2015)

Fulltext@MSK | Save

Oral statin use associated with reduced risk of monoclonal gammopathy of undetermined significance and multiple myeloma: A population-based nested case-control study

Meeting Abstract

McShane, C. M.; Tapper, C.; Murray, L. J.; Landgren, O.; Bradley, M. C.; Hughes, C. M.; Anderson, L. A.
European Journal of Cancer Care (2015)

Fulltext@MSK | Save

Stage 1 results from MDV3100-11: A 2-stage study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)

Meeting Abstract

Castan, J. C.; Schmid, P.; Awada, A.; Uppal, H.; Tudor, I. C.; Blaney, M. E.; Steinberg, J. L.; Yardley, D. A.; Hudis, C.; Traina, T. A.
Annals of Oncology (2015)

Fulltext@MSK | Save

Phase 2 study of nivolumab (anti-programmed death-1 [PD-1]) in patients (pts) with advanced, refractory squamous (SQ) non-small cell lung cancer (NSCLC)

Meeting Abstract

Zalcman, G.; Rizvi, N. A.; Lena, H.; Wolf, J.; Mazieres, J.; Antonia, S. J.; Minenza, E.; Planchard, D.; Lestini, B. J.; Ramalingam, S. S.
Annals of Oncology (2015)

Fulltext@MSK | Save

Phase 2, open-label, international, non-comparative study of MEDI4736 in patients with locally advanced or metastatic, PD-L1 +, stage 3B-4 NSCLC who have received ≥2 prior systemic treatment regimens (ATLANTIC)

Meeting Abstract

Gray, J. E.; Garassino, M. C.; Vansteenkiste, J. F.; Ballas, M.; Jayawardene, D.; Stockman, P. K.; Powderly, J. D.; Rizvi, N.
Annals of Oncology (2015)

Fulltext@MSK | Save

Psycho-oncology. 3rd ed

Book Whole

Oxford University Press (2015)

Fulltext@MSK | Save